1 |
Brackenborough K, Ellis H, Flight WG. Respiratory Viruses and Cystic Fibrosis. Semin Respir Crit Care Med 2023;44:196-208. [PMID: 36535663 DOI: 10.1055/s-0042-1758728] [Reference Citation Analysis]
|
2 |
de Granda-Orive JI, Martínez-García MÁ. What have we learnt from Covid-19 Pandemia? Looking to the future. Pulmonology 2023;29:108-10. [PMID: 36270889 DOI: 10.1016/j.pulmoe.2022.08.006] [Reference Citation Analysis]
|
3 |
Rachmawati E, Nurmansyah MI, Suraya I, Listiowati E, Kurniawan DW, Ahsan A. Association between cigarette smoking patterns and severity of COVID-19: Findings from a study in 15 private Hospitals in Indonesia. Tob Induc Dis 2023;21:27. [PMID: 36819958 DOI: 10.18332/tid/159622] [Reference Citation Analysis]
|
4 |
Spanakis M, Ioannou P, Tzalis S, Chouzouri F, Patelarou E, Kofteridis DP, Antoniou KM, Schiza SE, Patelarou A, Tzanakis N. Evaluation of Drug Interactions in Hospitalized Patients with Respiratory Disorders in Greece. Adv Respir Med 2023;91:74-92. [PMID: 36825942 DOI: 10.3390/arm91010008] [Reference Citation Analysis]
|
5 |
Bridi GDP, Tanni SE, Baldi BG. Current Understanding of Post-COVID Pulmonary Fibrosis: Where Are We? Arch Bronconeumol 2023;59:69-70. [PMID: 36041958 DOI: 10.1016/j.arbres.2022.07.014] [Reference Citation Analysis]
|
6 |
Martínez-Besteiro E, Molina-Molina M, Gaeta AM, Aburto M, Casanova Á, Rigual Bobillo J, Orozco S, Pérez Rojo R, Godoy R, López-Muñiz Ballesteros B, Pinillos Robles EJ, Sánchez Fraga S, Peña Miguel T, Balcells E, Laporta R, Rodríguez Portal JA, Herrera Lara S, Cabrera E, Acosta O, Peláez A, Valenzuela C. Impact of COVID-19 Infection on Patients with Preexisting Interstitial Lung Disease: A Spanish Multicentre Study. Arch Bronconeumol 2023:S0300-2896(23)00005-4. [PMID: 36732159 DOI: 10.1016/j.arbres.2023.01.001] [Reference Citation Analysis]
|
7 |
Mallah N, Pardo-Seco J, López-Pérez LR, González-Pérez JM, Rosón B, Otero-Barrós MT, Durán-Parrondo C, Nartallo-Penas V, Mirás-Carballal S, Rodríguez-Tenreiro C, Rivero-Calle I, Gómez-Carballa A, Salas A, Martinón-Torres F. Effectiveness of COVID-19 vaccine booster in the general population and in subjects with comorbidities. A population-based study in Spain. Environ Res 2022;215:114252. [PMID: 36096168 DOI: 10.1016/j.envres.2022.114252] [Reference Citation Analysis]
|
8 |
Jimenez Ruiz JA, Lopez Ramirez C, Lopez-Campos JL. Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion. Front Public Health 2022;10:1052241. [PMID: 36523581 DOI: 10.3389/fpubh.2022.1052241] [Reference Citation Analysis]
|
9 |
Figueira-Gonçalves JM, Golpe R. Medium- and Long-Term Consequences of SARS-CoV-2 Infection on COPD Patients. Arch Bronconeumol 2022;58:729-30. [PMID: 35697563 DOI: 10.1016/j.arbres.2022.05.009] [Reference Citation Analysis]
|
10 |
de Granda-orive JI, Solano-reina S, Jiménez-ruiz CA. Are Smoking and Vaping Risk Factors of Developing Long and Persistent Post-COVID-19? Open Respiratory Archives 2022;4:100195. [DOI: 10.1016/j.opresp.2022.100195] [Reference Citation Analysis]
|
11 |
Bitsani A, Garmpi A, Avramopoulos P, Spandidos DA, Fotakopoulos G, Papalexis P, Tarantinos K, Chlapoutakis S, Sklapani P, Trakas N, Georgakopoulou VE. COVID-19-associated pneumonia in Swyer-James-MacLeod syndrome: A case report. Med Int (Lond) 2022;2:28. [PMID: 36698912 DOI: 10.3892/mi.2022.53] [Reference Citation Analysis]
|
12 |
Zhao Y, Lukiw WJ. SARS-CoV-2 Neuroinvasion, Inflammatory Neurodegeneration and Alzheimer's Disease. Front Cell Neurosci 2022;16:937961. [DOI: 10.3389/fncel.2022.937961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|